Eagle Pharmaceuticals Provides Update on Bendamustine : comp

WOODCLIFF LAKE, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided an update on...

Related Keywords

United States , Gaza , Israel General , Israel , Japan , Ukraine , Russia , Delaware , Lisam Wilson , Slayback Pharma , Michael Graves , Acacia Pharma Inc , Trademark Office , Company Quarterly Reports On Form , Nasdaq , United States Court , Slayback Pharma Limited Liability Company , Site Communications Inc , Exchange Commission , Baxter Healthcare Corporation , Apotex Corp , Azurity Pharmaceuticals , Public Relations For Eagle Pharmaceuticals Inc , European Medicines Agency , Eagle Pharmaceuticals Inc , United States District Court , Company Annual Report On Form , Drug Administration , Investor Relations For Eagle Pharmaceuticals Inc , Apotex Inc , Federal Circuit , Orange Book , Interim Principal Executive Officer , Interim Executive Chairman , Eagle Pharmaceuticals , Acacia Pharma , Private Securities Litigation Reform Act , Nasdaq Listing Rules , Chief Executive Officer , Federal Drug Administration , Annual Report , Quarterly Reports , Site Communications , Nasdaq Egrx , Nc ,